BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 23229021)

  • 1. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of bone marrow‑derived endothelial progenitor cells overexpressing Delta‑like‑4 enhances functional neovascularization in ischemic myocardium.
    Huang H; Huang F; Huang JP
    Mol Med Rep; 2013 Nov; 8(5):1556-62. PubMed ID: 24002737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.
    Li H; Zuo S; He Z; Yang Y; Pasha Z; Wang Y; Xu M
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1772-81. PubMed ID: 20870802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
    Chen JJ; Zhou SH
    Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the survival and utility of pre-differentiated allogeneic MSC in ischemic heart.
    Xia C; Cao J
    Biochem Biophys Res Commun; 2013 Aug; 438(2):382-7. PubMed ID: 23899528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.
    Sun L; Cui M; Wang Z; Feng X; Mao J; Chen P; Kangtao M; Chen F; Zhou C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):779-84. PubMed ID: 17445769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.
    Payne TR; Oshima H; Okada M; Momoi N; Tobita K; Keller BB; Peng H; Huard J
    J Am Coll Cardiol; 2007 Oct; 50(17):1677-84. PubMed ID: 17950150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
    Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
    Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J; Huang Y; Takagawa J; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW; Su H
    J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
    Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
    Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.
    Song SW; Chang W; Song BW; Song H; Lim S; Kim HJ; Cha MJ; Choi E; Im SH; Chang BC; Chung N; Jang Y; Hwang KC
    Stem Cells; 2009 Jun; 27(6):1358-65. PubMed ID: 19489098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.